Rethinking Surgery.

OUR MISSION

Pioneer the next-generation quantitative surgical techniques.

We enable safe and efficient monitoring of tissues during cancer surgery without compromising workflows.

CHALLENGE

Surgeons regularly face problems during cancer surgery:

Marginum cancer screening icon

Tumour cells
left undetected 

Marginum cutting icon

Healthy tissues
unnecessarily resected

Marginum brains icon

Operative workflows
are complex

SOLUTION

Marginum enables unforeseen manual control by detecting tumours from surgical suction waste

magnifying glass and tissue

Precise detection
of tumour cells

Human body

Minimal damage
to healthy tissues 

checkmark

Simplified workflow
at all times

OUR PRODUCT

Effortless, near real-time operating Marginum device monitors the surgical suction fluids’ content based on fluorescence intensity.

The surgeon is informed, if any traces of tumour are present in the resected tissue with truly objective and precise feedback.

CONTACT US

Unobtrusive

Safe to use

Intuitive

Hardware-fixed interface with audio feedback from analysis

Economic

Design utilises renewable materials & production is planned with minimal carbon footprint

Reliable

Highly sensitive & specific analysis

Robust

Technically failsafe

Stand-alone

No secondary devices required for utilisation

Arto Immonen
“During neurosurgical operation, distinguishing healthy brain tissue from malignant tumour is challenging with contemporary methods.” 

– Arto Immonen
Department Chief Physician,
Kuopio University Hospital
”Monitoring of various fluorescent biomarkers in resected cancer tissue aspirates will be a breakthrough in oncological surgery.”

– Juha E Jääskeläinen
Professor & Medical Council,
Kuopio University Hospital
Juha Jääskeläinen

LATEST NEWS & PRESS

10.10.2022 | Kuopio Chamber of Commerce

TSLP winner Marginum increases the efficiency of cancer surgery

Marginum joins Kuopio Chamber of Commerce and the Finnish Startup Community after winning Tahko Ski Lift Pitch 2022.

4.10.2022 | University of Eastern Finland

Marginum selected by University of Eastern Finland to Stage Two

Marginum has been nominated by University of Eastern Finland (UEF) to participate at Stage Two competition in Berlin.

13.9.2022 | Kuopio Health

Smart tissue monitor helps the surgeon to identify cancer cells

Marginum joined Kuopio Health to further connect with research institutions and other member companies in the medical technology industry. 

6.9.2022 | Tekniikka&Talous

New device developed in Finland detects cancer better than surgeon

Cancerous tissue could be completely removed in the first operation. In this story, we’ll tell you what Marginum’s device is all about.

14.6.2022 | Business Kuopio

Marginum featured as one of rising stars in Kuopio start-up scene

Marginum Ltd, founded in autumn 2020, is developing next-generation technology for the removal of cancerous tumours.

27.4.2022 | Finnish Medical Journal

Smart tissue monitor detects cancer tissues from surgical waste

Precision techniques such as Marginum’s aspirate tissue monitoring enable unprecedently efficient identification of cancer tissue and the best possible treatment.

ABOUT US

Marginum is a medical device company based in Kuopio, Finland.
We prioritize patient welfare and aim to improve surgical outcomes with unique tissue sensing techniques. 

The team consists of multidisciplinary experts dedicated to improving pre-existent surgical workflows with data-driven solutions.

Samu Lehtonen

BM BSc

Chief Executive Officer
Business & Operation

Antti-Pekka Elomaa

MD PhD A/Prof Neurosurgery

Chairman of Board
Education & Design

Juho Leskinen

MEng

Chief Technology Officer
Engineering & Commercialization

Dmitry Semenov

MSc PhD

Chief Scientific Officer
Prototyping & Optical systems

OUR PARTNERS

Nostetta
Business Finland
University of Eastern Finland
Kys

CONTACT

Contact us and learn more about the next steps
of our mission. 

Location: Kuopio, Finland

Email: info@marginum.com